Capital Fund Management (CFM)’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75M | Buy |
+49,805
| New | +$2.75M | 0.01% | 553 |
|
|
2025
Q1 | – | Sell |
-28,058
| Closed | -$1.08M | – | 1120 |
|
|
2024
Q4 | $1.08M | Buy |
+28,058
| New | +$1.08M | ﹤0.01% | 669 |
|
|
2023
Q4 | – | Sell |
-12,629
| Closed | -$211K | – | 1013 |
|
|
2023
Q3 | $211K | Sell |
12,629
-13,976
| -53% | -$233K | ﹤0.01% | 622 |
|
|
2023
Q2 | $735K | Buy |
+26,605
| New | +$735K | ﹤0.01% | 535 |
|
|
2022
Q3 | – | Sell |
-116,807
| Closed | -$924K | – | 845 |
|
|
2022
Q2 | $924K | Buy |
+116,807
| New | +$924K | 0.01% | 474 |
|